FDA Adverse Event
Injury
Summary report: N
INGEVITY+
MDR report key: 20123444
·
Received September 3, 2024
Report
- Report Number
- 2124215-2024-54810
- Event Type
- Injury
- Date Received
- September 3, 2024
- Date of Event
- August 5, 2024
- Report Date
- September 25, 2024
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NVN
- UDI-DI
- 00802526604522
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD PACING FAILURE AFTER IMPLANTATION AND ALSO EXHIBITED HIGH PACING THRESHOLDS. IN ADDITION, THE PHYSICIAN BELIEVES THAT IT WAS DUE TO DISLODGEMENT. THIS LEAD WAS SURGICALLY REVISE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Description of Event or Problem · 0
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD PACING FAILURE AFTER IMPLANTATION AND ALSO EXHIBITED HIGH PACING THRESHOLDS. IN ADDITION, THE PHYSICIAN BELIEVES THAT IT WAS DUE TO DISLODGEMENT. THIS LEAD WAS SURGICALLY REVISE AND REMAINS IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 899505 | INGEVITY+ | IMPLANTABLE LEAD | NVN | BOSTON SCIENTIFIC CORPORATION | 7842 | 1298756 | 00802526604522 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Male | Required Intervention| H |